MedTrace Logo

Youth Partners in Care: Depression and Quality Improvement

NCT02030782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 418

Last updated 2014-01-09

No results posted yet for this study

Summary

This randomized effectiveness trial evaluates a quality improvement intervention aimed at providing access to evidence-based depression treatments (particularly cognitive-behavior therapy for depression and or pharmacotherapy) through primary care for youth ages 13-21, as compared to enhanced usual care. The major hypothesis is that the quality improvement intervention will be associated with improved outcomes, relative to enhanced usual care.

Conditions

Interventions

OTHER

Quality Improvement (QI) for depression

Major intervention components included a) expert leader teams who planned and implemented the intervention at each clinic, b) care managers who supported primary care clinicians with depression evaluation and management, c) access to cognitive-behavior therapy for depression within each primary care clinic, and d) patient and provider choice regarding treatment modality.

OTHER

Usual Care

Usual care enhanced by provider education regarding depression evaluation and management

Sponsors & Collaborators

  • RAND

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Venice Family Clinic

    collaborator OTHER

  • Agency for Healthcare Research and Quality (AHRQ)

    lead FED

Principal Investigators

  • Joan R Asarnow, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31
Primary Completion
2003-12-31
Completion
2003-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030782 on ClinicalTrials.gov